BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28636094)

  • 41. [The influence of additive clonal chromosome abnormalities in Ph negative cells on the efficacy of chronic myeloid leukemia].
    Zhao HF; Zhang Y; Zu YL; Li Z; Zhou J; Yu FK; Hu JY; Wei XD; Song YP
    Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):803-807. PubMed ID: 31665854
    [No Abstract]   [Full Text] [Related]  

  • 42. [Analysis of the Relationship between Cytogenetic Changes and Course Evolution of Patients with CML during TKI Treatment].
    Wang K; Liu T; Dai J; Pang YX; Wang Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):136-140. PubMed ID: 32027266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rare monosomy 7 and deletion 7p at diagnosis of chronic myeloid leukemia in accelerated phase.
    Alswied A; Rehman A; Lai LW; Duran J; Sardar M; Proytcheva MA
    Cancer Genet; 2021 Apr; 252-253():111-114. PubMed ID: 33497941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population.
    Mu Q; Ma Q; Wang Y; Chen Z; Tong X; Chen FF; Lu Y; Jin J
    Ann Hematol; 2012 Jul; 91(7):1065-72. PubMed ID: 22349721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytogenetic and molecular studies in patients with chronic myelogenous leukemia without Ph chromosome and with unusual Ph translocation].
    Xue YQ
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):209-12, 252-3. PubMed ID: 8395313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
    Larsson N; Billström R; Lilljebjörn H; Lassen C; Richter J; Ekblom M; Fioretos T
    Cancer Genet Cytogenet; 2010 Jun; 199(2):89-95. PubMed ID: 20471511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic myeloid leukemia: cytogenetic methods and applications for diagnosis and treatment.
    Morris CM
    Methods Mol Biol; 2011; 730():33-61. PubMed ID: 21431633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytogenetic investigation in chronic myeloid leukemia: study from an Indian population.
    Chavan D; Ahmad F; Iyer P; Dalvi R; Kulkarni A; Mandava S; Das BR
    Asian Pac J Cancer Prev; 2006; 7(3):423-6. PubMed ID: 17059336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trisomy 6 in a CML patient receiving imatinib mesylate therapy.
    Zámecníkova A; Al Bahar S; Ramesh P
    Leuk Res; 2008 Sep; 32(9):1454-7. PubMed ID: 18294688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Occurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatments.
    Sheng G; Xue M; Wang Q; Wen L; Chen S; Zhang X; Yang X
    Leuk Lymphoma; 2019 Dec; 60(14):3503-3511. PubMed ID: 31282805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Which method better evaluates the molecular response in newly diagnosed chronic phase chronic myeloid leukemia patients with imatinib treatment, BCR-ABL(IS) or log reduction from the baseline level?
    Qin YZ; Jiang Q; Jiang H; Li JL; Li LD; Zhu HH; Lai YY; Lu XJ; Liu YR; Jiang B; Huang XJ
    Leuk Res; 2013 Sep; 37(9):1035-40. PubMed ID: 23810191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy.
    Quintás-Cardama A; Kantarjian H; Abruzzo LV; Cortes J
    Leukemia; 2007 Nov; 21(11):2394-6. PubMed ID: 17690707
    [No Abstract]   [Full Text] [Related]  

  • 56. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
    Kantarjian HM; Talpaz M; O'Brien S; Smith TL; Giles FJ; Faderl S; Thomas DA; Garcia-Manero G; Issa JP; Andreeff M; Kornblau SM; Koller C; Beran M; Keating M; Rios MB; Shan J; Resta D; Capdeville R; Hayes K; Albitar M; Freireich EJ; Cortes JE
    Clin Cancer Res; 2002 Jul; 8(7):2177-87. PubMed ID: 12114418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Chronic myeloid leukemia without Philadelphia chromosome (Ph-negative CML)].
    Haus O
    Acta Haematol Pol; 1993; 24(3):221-5. PubMed ID: 8249537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis: clinical features and course of M-bcr negative and M-bcr positive CML.
    Dobrovic A; Morley AA; Seshadri R; Januszewicz EH
    Leukemia; 1991 Mar; 5(3):187-90. PubMed ID: 2013977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The detection of Philadelphia chromosome negative metaphases in long-term bone marrow cultures of the peripheral blood from patients with chronic myeloid leukemia predicts response to interferon-alpha 2a.
    Gronthos S; To LB; Moore S; Suttle JM; Juttner CA
    Leukemia; 1992 Dec; 6(12):1246-9. PubMed ID: 1453769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.